EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

L. E. L. Hendriks, E. F. Smit, B. A. H. Vosse, W. W. Mellema, D. A. M. Heideman, G. P. Bootsma, M. Westenend, C. Pitz, G. J. de Vries, R. Houben, K. Grunberg, M. Bendek, E-J M. Speel, A-M C. Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)86-91
JournalLung Cancer
Volume84
Issue number1
DOIs
Publication statusPublished - Apr 2014

Keywords

  • NSCLC
  • EGFR
  • KRAS
  • Brain metastases
  • Bone metastases
  • Survival

Cite this

Hendriks, L. E. L., Smit, E. F., Vosse, B. A. H., Mellema, W. W., Heideman, D. A. M., Bootsma, G. P., Westenend, M., Pitz, C., de Vries, G. J., Houben, R., Grunberg, K., Bendek, M., Speel, E-J. M., & Dingemans, A-M. C. (2014). EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases? Lung Cancer, 84(1), 86-91. https://doi.org/10.1016/j.lungcan.2014.01.006